In summary, IL-6 plasma levels strongly correlated with [18F]FMISO PET-detected intratumoral hypoxia in HNSCC patients and were able to significantly predict a prognostically favorable early hypoxia response within the first 2 weeks of chemoradiation. The gene discussed is IL6; the disease is head and neck squamous cell carcinoma.